The last group of 15 Chinese volunteers who received AIDS vaccinotherapy in Nanning reported no adverse drug reaction (ADR) after 24 hours' observation. The 15 volunteers are the last group of those who have received the fourth and also the last vaccines on Saturday in Nanning. Thus far, all the human trials of a first AIDS vaccine, developed by China, have been accomplished, according to the overseas edition of People's Daily on Monday.

The 49 Chinese volunteers who have received the human trials of a new AIDS vaccine are divided into eight groups. Six groups receive single vaccine while the remaining two groups have combined ones. The first seven groups received vaccine injections before September this year according to a planned program. The eighth group consisted of 15 volunteers got the injections on Saturday, said Chen Jie, deputy director of the Guangxi regional disease prevention and control center.

Chen Jie said the first 24 hours are a vital period for observation. So far, no volunteers have reported ADR after 24 hours' observation. They entered a relatively stable period for observation. He said, "The clinical data will be obtained in June next year after the center finishes observation of all the volunteers, which will offer a scientific foundation for whether the center can go on with the second phase of AIDS vaccine test. In view of the present experimentation, the test has been going on smoothly. Now we are considering the second-phase test, and technical preparation is under way."

The first group of eight volunteers receiving the vaccines was launched on March 12 this year by the Guangxi regional disease prevention and control center. This is the first time that China has made the clinical research on AIDS vaccine.

By People's Daily Online